238 related articles for article (PubMed ID: 24642859)
1. Prognostic role of NLR in urinary cancers: a meta-analysis.
Wei Y; Jiang YZ; Qian WH
PLoS One; 2014; 9(3):e92079. PubMed ID: 24642859
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
3. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis.
Wang Z; Wang X; Wang WD; Zheng GY; Guo H; Zhang YS
Chin Med Sci J; 2020 Sep; 35(3):262-271. PubMed ID: 32972504
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.
Chen J; Deng Q; Pan Y; He B; Ying H; Sun H; Liu X; Wang S
FEBS Open Bio; 2015; 5():502-7. PubMed ID: 26137435
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis.
Luo Y; She DL; Xiong H; Fu SJ; Yang L
Medicine (Baltimore); 2015 Oct; 94(40):e1670. PubMed ID: 26448011
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
9. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.
Tang H; Li B; Zhang A; Lu W; Xiang C; Dong J
PLoS One; 2016; 11(7):e0159447. PubMed ID: 27427969
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of PLR in various cancers: a meta-analysis.
Zhou X; Du Y; Huang Z; Xu J; Qiu T; Wang J; Wang T; Zhu W; Liu P
PLoS One; 2014; 9(6):e101119. PubMed ID: 24968121
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
[TBL] [Abstract][Full Text] [Related]
14. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.
Tang X; Du P; Yang Y
Int J Clin Oncol; 2017 Oct; 22(5):817-825. PubMed ID: 28752351
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.
Bowen RC; Little NAB; Harmer JR; Ma J; Mirabelli LG; Roller KD; Breivik AM; Signor E; Miller AB; Khong HT
Oncotarget; 2017 May; 8(19):32171-32189. PubMed ID: 28418870
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses.
Mjaess G; Chebel R; Karam A; Moussa I; Pretot D; Abi Tayeh G; Sarkis J; Semaan A; Peltier A; Aoun F; Albisinni S; Roumeguère T
Acta Oncol; 2021 Jun; 60(6):704-713. PubMed ID: 33586577
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
Wang J; Zhou X; Liu Y; Li Z; Li X
PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
